Inhibition of bone morphogenetic protein signaling reduces viability, growth and migratory potential of non-small cell lung carcinoma cells.
CONCLUSIONS: BMP signaling inhibition in LCLC-103H cells leads to reduced growth and proliferation, hindered migration and accelerated cell death. The findings contribute to the pool of evidence on BMP signaling in lung cancer with a possibility of introducing BMP signaling inhibition as a novel therapeutic approach for the disease.
PMID: 31531741 [PubMed - as supplied by publisher]
Source: Clin Med Res - Category: Research Authors: Mihajlović J, Diehl LAM, Hochhaus A, Clement JH Tags: J Cancer Res Clin Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Epithelial Cancer | Genetics | Lung Cancer | Non-Small Cell Lung Cancer | Research